Marksans Pharma Share Price History and Returns 1995 to 2026
|
Marksans Pharma Limited |
|||
|
Price: ₹249.76 (-1.03%) | ||
| 52 Week Low: ₹155.00 52 Week High: ₹266.60 |
|||
| Market Capital: 8,619.62 Crore (Mid-cap) | |||
| Healthcare -> Drug Manufacturers—General | |||
Show Table of Contents
- 1: Marksans Pharma Stock Highlights
- 1.1: 52-Week High Low
- 1.2: All Time High
- 2: Marksans Pharma Recent Performance
- 3: Marksans Pharma Stock Price Chart From 2002 to 2026
- 4: Marksans Pharma Stock Price History Table From 2002 to 2026
- 5: Analyzing the Impact of Investing in Marksans Pharma
- 5.1: Marksans Pharma Stock Returns In Last 5 Years
- 5.2: Marksans Pharma Stock Returns In Last 10 Years
- 5.3: Marksans Pharma Stock Returns In Last 15 Years
- 5.4: Marksans Pharma Stock Returns In Last 20 Years
- 6: Marksans Pharma Returns vs Bank FD Returns
Marksans Pharma Stock Highlights
As of 15 Jun 2026, Marksans Pharma Stock price is ₹249.76 which is ₹16.84 below 52-week high of ₹266.60 and ₹94.76 above 52-week low of ₹155.00
52-Week High Low
- Marksans Pharma 52-Week High is ₹266.60 occurred on 07 Jul 2025
- Marksans Pharma 52-Week Low is ₹155.00 occurred on 30 Mar 2026
All Time High
- The all-time high or the highest price that Marksans Pharma stocks have ever touched was ₹358.70 and this occurred on Dec 2024.
- The highest closing price at which Marksans Pharma stocks have ever closed was ₹342.75 recorded on Nov 2024.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Marksans Pharma Recent Performance
Over the past 15 trading days, the value of Marksans Pharma's stock has decreased by ₹5.03 (-1.97%). On 26 May 2026, its one share was worth ₹254.79 and by 15 Jun 2026, the value dropped to ₹249.76. During this period it created a highest high of ₹264.40 and lowest low of ₹218.00.
Click on legend items to show/hide respective price lines
Marksans Pharma Stock Price Chart From 2002 to 2026
Click on legend items to show/hide respective price lines
Marksans Pharma Stock Price History Table From 2002 to 2026
| Year | Marksans Pharma | YOY Chg% | ↑High - ↓Low |
|---|---|---|---|
| 2026 | ₹252.37 | 39.9% |
↑ ₹264.00 ↓ ₹155.00 |
| 2025 | ₹180.29 | -39.3% |
↑ ₹308.00 ↓ ₹162.00 |
| 2024 | ₹296.65 | 84.1% |
↑ ₹358.00 ↓ ₹130.00 |
| 2023 | ₹161.10 | 176.5% |
↑ ₹172.00 ↓ ₹57.90 |
| 2022 | ₹58.25 | -3.2% |
↑ ₹65.00 ↓ ₹38.60 |
| 2021 | ₹60.15 | -0.9% |
↑ ₹97.60 ↓ ₹49.15 |
| 2020 | ₹60.65 | 263.1% |
↑ ₹66.20 ↓ ₹9.85 |
| 2019 | ₹16.70 | -40.1% |
↑ ₹28.65 ↓ ₹11.40 |
| 2018 | ₹27.85 | -30.3% |
↑ ₹50.35 ↓ ₹23.55 |
| 2017 | ₹39.95 | 0.2% |
↑ ₹58.25 ↓ ₹34.20 |
| 2016 | ₹39.85 | -62.0% |
↑ ₹106.00 ↓ ₹33.50 |
| 2015 | ₹104.70 | 70.3% |
↑ ₹115.00 ↓ ₹51.35 |
| 2014 | ₹61.45 | 249.1% |
↑ ₹69.35 ↓ ₹14.60 |
| 2013 | ₹17.60 | 417.6% |
↑ ₹20.65 ↓ ₹2.75 |
| 2012 | ₹3.40 | 100.0% |
↑ ₹4.45 ↓ ₹1.30 |
| 2011 | ₹1.70 | -54.1% |
↑ ₹3.80 ↓ ₹1.65 |
| 2010 | ₹3.70 | -35.1% |
↑ ₹6.65 ↓ ₹3.05 |
| 2009 | ₹5.70 | -22.0% |
↑ ₹9.30 ↓ ₹3.60 |
| 2008 | ₹7.30 | -76.6% |
↑ ₹34.88 ↓ ₹5.10 |
| 2007 | ₹31.08 | 188.3% |
↑ ₹31.08 ↓ ₹4.40 |
| 2006 | ₹10.78 | -48.7% |
↑ ₹30.19 ↓ ₹8.77 |
| 2005 | ₹21.00 | 15.3% |
↑ ₹39.50 ↓ ₹18.28 |
| 2004 | ₹18.21 | 247.5% |
↑ ₹18.70 ↓ ₹3.32 |
| 2003 | ₹5.24 | 118.3% |
↑ ₹5.72 ↓ ₹0.87 |
| 2002 | ₹2.40 | - |
↑ ₹2.40 ↓ ₹2.40 |
Analyzing the Impact of Investing in Marksans Pharma
Marksans Pharma Stock price in the year 2002 was ₹2.40. If you had invested ₹10,000 in Marksans Pharma Stock in 2002, in 24 years, your investment would have grown to ₹10.51 Lakh by the end of 2026. This represents a positive return of 10,415% from 2002 to 2026, with a compound annual growth rate (CAGR) of 21.4%.
Marksans Pharma Stock Returns In Last 5 Years
- Its highest stock price in the last 5 years was: ₹358.70 and lowest was: ₹38.60
- Marksans Pharma Stock price in 2021 was ₹60.15
- By 2026, its stock price rose to ₹252.37
- It gave a positive return of over 319.6% with a CAGR of 33.2% over the last 5 years
- If you had invested ₹10,000 in Marksans Pharma in 2021 then in 5 years, your investment would have grown to ₹41,956.77 by 2026, which is 4.20 times of your initial investment.
Marksans Pharma Stock Returns In Last 10 Years
- Its highest stock price in the last 10 years was: ₹358.70 and lowest was: ₹9.85
- Marksans Pharma Stock price in 2016 was ₹39.85
- By 2026, its stock price rose to ₹252.37
- It gave a positive return of over 533.3% with a CAGR of 20.3% over the last 10 years
- If you had invested ₹10,000 in Marksans Pharma in 2016 then in 10 years, your investment would have grown to ₹63,329.98 by 2026, which is 6.33 times of your initial investment.
Marksans Pharma Stock Returns In Last 15 Years
- Its highest stock price in the last 15 years was: ₹358.70 and lowest was: ₹1.30
- Marksans Pharma Stock price in 2011 was ₹1.70
- By 2026, its stock price rose to ₹252.37
- It gave a positive return of over 14,745.3% with a CAGR of 39.6% over the last 15 years
- If you had invested ₹10,000 in Marksans Pharma in 2011 then in 15 years, your investment would have grown to ₹14.84 Lakh by 2026, which is 148.45 times of your initial investment.
Marksans Pharma Stock Returns In Last 20 Years
- Its highest stock price in the last 20 years was: ₹358.70 and lowest was: ₹1.30
- Marksans Pharma Stock price in 2006 was ₹10.78
- By 2026, its stock price rose to ₹252.37
- It gave a positive return of over 2,241.1% with a CAGR of 17.1% over the last 20 years
- If you had invested ₹10,000 in Marksans Pharma in 2006 then in 20 years, your investment would have grown to ₹2.34 Lakh by 2026, which is 23.41 times of your initial investment.
Marksans Pharma Returns vs Bank FD Returns
| Investment Type | Initial Amount | Final Value | Total Returns |
|---|---|---|---|
| Marksans Pharma Shares | ₹10,000 | ₹10.51 Lakh | 10,415.4% |
| Bank FD (Simple Interest) | ₹10,000 | ₹24,400 | 144.0% |
| Bank FD (Compound Interest) | ₹10,000 | ₹40,489.34 | 304.9% |
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.




